Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.76) per share. This is a 79.51 percent increase over losses of $(3.71) per share from the same period last year. The company reported $1.24 million in sales this quarter.
Tarsus Pharmaceuticals Q3 EPS $(0.76) Up From $(3.71) YoY, Sales $1.24M
Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.76) per share. This is a 79.51 percent increase over losses of $(3.71) per share from the same period last year. The company reported $1.24 million
